Investors may be a bit weary of jumping into PROLOR Biotech (PBTH) after the company 
Below is a look at some of the headlines for companies that made news in the healthcare sector on May 18, 2012.
Biotech and medtech expose investors to rapid growth in healthcare innovation. Chief Investment Strategist Alex Daley of Casey's Extraordinary Technology matches science to unmet needs to bring big ideas and big returns to investors.
Shares of Adventrx Pharmaceuticals Inc (Amex:ANX) are trading -87.41 % from their 52-Wk High ($ 4.21). With two possible pending Phase III trial initiations on-tap and 
Newly discovered biomarkers could provide physicians with information that will aid in the diagnosis and treatment of disease. The big question for investors is whether, in light of the recent Supreme Court ruling Mayo Collaborative Services Inc. v. Prometheus Laboratories, companies will be able to profit from that innovation.
about 41 minutes ago
$AMLN Said to Attract Interest From Pfizer, AstraZeneca - Businessweek http://t.co/PFKT6LE8
about 1 hour ago
Stock Market: Stocks Extend Losing Streak http://t.co/ZmZxvJiO
about 2 hours ago
Cancer Survivors Who Exercise Live Longer http://t.co/U4MhX04a
about 3 hours ago
Colon cancer screenings that don’t require laxatives are almost as effective as colonoscopies and may encourage more tests http://j.m…
about 4 hours ago
Testing a Drug That May Stop Alzheimer’s Before It Starts $RHHBY http://t.co/Wjgw15IS
about 4 hours ago
Two patients get eye stem cells transplanted to restore sight http://t.co/HHYZlFFT
about 4 hours ago
US Senate call to scrap drug patents: http://t.co/W1BOuxJp
about 5 hours ago
http://t.co/MAgh4Xke
Free Phone Trade Alerts
